A Real-World Analysis of Immune Checkpoint Inhibitor-Based Therapy After Osimertinib Treatment in Patients With EGFR-Mutant NSCLC

Autor: Morimoto, Kenji, Sawada, Ryo, Yamada, Tadaaki, Azuma, Koichi, Ito, Kentaro, Goto, Yasuhiro, Kimura, Hideharu, Harada, Taishi, Shiotsu, Shinsuke, Tamiya, Nobuyo, Chihara, Yusuke, Takeda, Takayuki, Hiranuma, Osamu, Hasegawa, Isao, Morimoto, Yoshie, Iwasaku, Masahiro, Tokuda, Shinsaku, Takayama, Koichi
Zdroj: In JTO Clinical and Research Reports September 2022 3(9)
Databáze: ScienceDirect